Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test.
123I-IMP
Cerebral blood flow
Cerebrovascular reactivity
Single-photon emission computed tomography
Journal
Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
02
10
2021
accepted:
17
11
2021
pubmed:
2
1
2022
medline:
5
4
2022
entrez:
1
1
2022
Statut:
ppublish
Résumé
The γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) is a new method for quantifying cerebral blood flow (CBF) using single-photon emission computed tomography (SPECT) and [ The REICA and Graph-Plot (GP) methods were used to calculate mean CBF (mCBF) for 92 acquisitions (rest: 57, stress: 35) and cerebrovascular reactivity (CVR) in 33 patients. To obtain stress data, 15 mg/kg of acetazolamide was injected intravenously 10 min before the administration of For mCBF, the correlation coefficients (r) were 0.792 for the REICA method and 0.636 for the GP method. For CVR, r values were 0.660 for the REICA method and 0.578 for the GP method. In both acquisitions, the REICA method had a stronger correlation with the ARG method than the GP method. For mCBF, there was a significant difference in the correlation coefficient between the two correlation coefficients (p < 0.01). The REICA method was more accurate than the GP method in quantifying CBF and closer to the ARG method. The REICA method, which is a noninvasive method of cerebral blood flow quantification using
Identifiants
pubmed: 34973145
doi: 10.1007/s12149-021-01700-w
pii: 10.1007/s12149-021-01700-w
pmc: PMC8897379
doi:
Substances chimiques
Radiopharmaceuticals
0
Iofetamine
C2A5X08042
Acetazolamide
O3FX965V0I
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
279-284Subventions
Organisme : CSRD VA
ID : 1
Pays : United States
Organisme : Nihon Medi-Physics
ID : 2
Organisme : CSRD VA
ID : 1
Pays : United States
Informations de copyright
© 2021. The Author(s).
Références
Kim KM, Watabe H, Hayashi T, Hayashida K, Katafuchi T, Enomoto N, Ogura T, Shidahara M, Takikawa S, Eberl S, Nakazawa M, Iida H. Quantitative mapping of basal and vasareactive cerebral blood flow using split-dose
doi: 10.1016/j.neuroimage.2006.06.064
pubmed: 17035048
Ferrando R, Damian A. Brain SPECT as a biomarker of neurodegeneration in dementia in the era of molecular imaging: still a valid option? Front Neurol. 2021;10(12): 629442. https://doi.org/10.3389/fneur.2021.629442 .
doi: 10.3389/fneur.2021.629442
Mizumura S, Nakagawara J, Takahashi M, Kumita S, Cho K, Nakajo H, Toba M, Kumazaki T. Three-dimensional display in staging hemodynamic brain ischemia for JET study: objective evaluation using SEE analysis and 3D-SSP display. Ann Nucl Med. 2004;18(1):13–21. https://doi.org/10.1007/BF02985609 .
doi: 10.1007/BF02985609
pubmed: 15072179
Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke. 2002;33(7):1857–62. https://doi.org/10.1161/01.str.0000019511.81583.a8 .
doi: 10.1161/01.str.0000019511.81583.a8
pubmed: 12105366
Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke. 2001;32(9):2110–6. https://doi.org/10.1161/hs0901.095692 .
doi: 10.1161/hs0901.095692
pubmed: 11546904
Oshida S, Ogasawara K, Saura H, Yoshida K, Fujiwara S, Kojima D, Kobayashi M, Yoshida K, Kubo Y, Ogawa A. Does preoperative measurement of cerebral blood flow with acetazolamide challenge in addition to preoperative measurement of cerebral blood flow at the resting state increase the predictive accuracy of development of cerebral hyperperfusion after carotid endarterectomy? Results from 500 cases with brain perfusion single-photon emission computed tomography study. Neurol Med Chir (Tokyo). 2015;55(2):141–8. https://doi.org/10.2176/nmc.oa.2014-0269 .
doi: 10.2176/nmc.oa.2014-0269
Hosoda K, Kawaguchi T, Shibata Y, Kamei M, Kidoguchi K, Koyama J, Fujita S, Tamaki N. Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke. 2001;32(7):1567–73. https://doi.org/10.1161/01.str.32.7.1567 .
doi: 10.1161/01.str.32.7.1567
pubmed: 11441203
Kaku Y, Yoshimura S, Kokuzawa J. Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol. 2004;25(8):1403–8.
pubmed: 15466341
pmcid: 7975476
Ogasawara K, Yukawa H, Kobayashi M, Mikami C, Konno H, Terasaki K, Inoue T, Ogawa A. Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. J Neurosurg. 2003;99(3):504–10. https://doi.org/10.3171/jns.2003.99.3.0504 .
doi: 10.3171/jns.2003.99.3.0504
pubmed: 12959438
Kameyama M. Lassen’s equation is a good approximation of permeability-surface model: new α values for
doi: 10.1038/jcbfm.2014.64
pubmed: 24736892
pmcid: 4083378
Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, Uemura K. Quantitative mapping of regional cerebral blood flow using iodine-
pubmed: 7989987
Iida H, Itoh H, Bloomfield PM, Munaka M, Higano S, Murakami M, Inugami A, Eberl S, Aizawa Y, Kanno I, et al. A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling. Eur J Nucl Med. 1994;21(10):1072–84. https://doi.org/10.1007/BF00181062 .
doi: 10.1007/BF00181062
pubmed: 7828617
Okamoto K, Ushijima Y, Okuyama C, Nakamura T, Nishimura T. Measurement of cerebral blood flow using graph plot analysis and I-123 iodoamphetamine. Clin Nucl Med. 2002;27(3):191–6. https://doi.org/10.1097/00003072-200203000-00009 .
doi: 10.1097/00003072-200203000-00009
pubmed: 11852307
Kameyama M, Watanabe K. A new non-invasive graphical method for quantification of cerebral blood flow with [
doi: 10.1007/s12149-018-1282-8
pubmed: 30046997
pmcid: 6208854
Maruko M, Kameyama M, Sakai J, Shirasaki S, Fujiwara H. The REICA method for quantification of cerebral blood flow is less affected by lung washout of [
doi: 10.1007/s12149-020-01499-y
pubmed: 32661591
Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. A quantitative approach to technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med. 1992;19(3):195–200. https://doi.org/10.1007/BF00173281 .
doi: 10.1007/BF00173281
pubmed: 1572384
Ishii K, Uemura T, Miyamoto N, Yoshikawa T, Yamaguchi T, Ashihara T, Ohtani Y. Regional cerebral blood flow in healthy volunteers measured by the graph plot method with iodoamphetamine SPECT. Ann Nucl Med. 2011;25(4):255–60. https://doi.org/10.1007/s12149-010-0451-1 .
doi: 10.1007/s12149-010-0451-1
pubmed: 21153452
Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab. 2001;21(12):1472–9. https://doi.org/10.1097/00004647-200112000-00012 .
doi: 10.1097/00004647-200112000-00012
pubmed: 11740209